Aldesleukin Suspended Phase 2 Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
SuspendedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003067Biological Therapy in Treating Patients With Primary or Advanced Glioma